Literature DB >> 12791926

Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated.

S J Weissenborn1, A M Funke, M Hellmich, P Mallmann, P G Fuchs, H J Pfister, U Wieland.   

Abstract

Human papillomavirus (HPV) DNA loads of six oncogenic HPV types were measured by real-time PCR in cervical scrapes of human immunodeficiency virus (HIV)-infected and uninfected women. In both groups, HPV loads increased with the grade of cervical disease. HIV infection did not affect HPV loads in low-grade lesions but was associated with significantly higher HPV loads in severe dysplasia; highest loads were found in advanced HIV disease. Our data reflect the aggressive course of HPV infection in HIV-positive women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791926      PMCID: PMC156503          DOI: 10.1128/JCM.41.6.2763-2767.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.

Authors:  J M Palefsky; H Minkoff; L A Kalish; A Levine; H S Sacks; P Garcia; M Young; S Melnick; P Miotti; R Burk
Journal:  J Natl Cancer Inst       Date:  1999-02-03       Impact factor: 13.506

2.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus.

Authors:  M Maiman; R G Fruchter; A Sedlis; J Feldman; P Chen; R D Burk; H Minkoff
Journal:  Gynecol Oncol       Date:  1998-03       Impact factor: 5.482

Review 4.  Primer-directed sequencing of human papillomavirus types.

Authors:  H Delius; B Hofmann
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

Review 5.  Natural history of cervical intraepithelial neoplasia: a critical review.

Authors:  A G Ostör
Journal:  Int J Gynecol Pathol       Date:  1993-04       Impact factor: 2.762

6.  Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

Authors:  R J Kurman; D E Henson; A L Herbst; K L Noller; M H Schiffman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

7.  Serial quantitation of HPV-16 in the smears of women with mild and moderate dyskaryosis.

Authors:  G Flannelly; G Jiang; D Anderson; W Melvin; E Mann; H Kitchener
Journal:  J Med Virol       Date:  1995-09       Impact factor: 2.327

8.  Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.

Authors:  N Ylitalo; P Sørensen; A M Josefsson; P K Magnusson; P K Andersen; J Pontén; H O Adami; U B Gyllensten; M Melbye
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women.

Authors:  C Six; I Heard; C Bergeron; G Orth; J D Poveda; P Zagury; P Cesbron; C Crenn-Hébert; R Pradinaud; M Sobesky; C Marty; M L Babut; J E Malkin; A Odier; S Fridmann; J P Aubert; J B Brunet; I de Vincenzi
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

View more
  13 in total

1.  Quantification of beta-human papillomavirus DNA by real-time PCR.

Authors:  Sönke J Weissenborn; Ulrike Wieland; Monika Junk; Herbert Pfister
Journal:  Nat Protoc       Date:  2010-01       Impact factor: 13.491

2.  High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.

Authors:  Paul H M Smits; Remco Bakker; Eefje Jong; Jan Willem Mulder; Pieter L Meenhorst; Bernhard Kleter; Leen-Jan van Doorn; Wim G V Quint
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients.

Authors:  Sönke Weissenborn; Rachel E Neale; Tim Waterboer; Damiano Abeni; Jan Nico Bouwes Bavinck; Adele C Green; Catherine A Harwood; Sylvie Euvrard; Mariet C W Feltkamp; Maurits N C de Koning; Luigi Naldi; Wim G V Quint; Gianpaolo Tessari; Charlotte M Proby; Ulrike Wieland; Herbert Pfister
Journal:  Med Microbiol Immunol       Date:  2011-07-27       Impact factor: 3.402

4.  The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.

Authors:  S Mikolajczak; G Quante; S Weissenborn; A Wafaisade; U Wieland; J C Lüers; J P Klussmann; D Beutner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-06       Impact factor: 2.503

5.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

6.  Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-seropositive women with high-grade squamous intraepithelial lesions than in those with normal cytology smears.

Authors:  Jonas Lefevre; Catherine Hankins; Deborah Money; Anita Rachlis; Karina Pourreaux; François Coutlée
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.

Authors:  Nadine C Olthof; Christian U Huebbers; Jutta Kolligs; Mieke Henfling; Frans C S Ramaekers; Iris Cornet; Josefa A van Lent-Albrechts; Alexander P A Stegmann; Steffi Silling; Ulrike Wieland; Thomas E Carey; Heather M Walline; Susanne M Gollin; Thomas K Hoffmann; Johan de Winter; Bernd Kremer; Jens P Klussmann; Ernst-Jan M Speel
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

8.  AKT1 loss correlates with episomal HPV16 in vulval intraepithelial neoplasia.

Authors:  Arucha L Ekeowa-Anderson; Karin J Purdie; Karen Gibbon; Carolyn R Byrne; Jeffrey M Arbeit; Catherine A Harwood; Ryan F L O'Shaughnessy
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

9.  The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa.

Authors:  Christopher Ng'andwe; John J Lowe; Paula J Richards; Lara Hause; Charles Wood; Peter C Angeletti
Journal:  BMC Infect Dis       Date:  2007-07-16       Impact factor: 3.090

10.  Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression.

Authors:  Nadine C Olthof; Ernst-Jan M Speel; Jutta Kolligs; Annick Haesevoets; Mieke Henfling; Frans C S Ramaekers; Simon F Preuss; Uta Drebber; Ulrike Wieland; Steffi Silling; Wan L Lam; Emily A Vucic; Bernd Kremer; Jens-P Klussmann; Christian U Huebbers
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.